Evaluation of the Cost-effectiveness of Services for Schizophrenia in the UK Across the Entire Care Pathway in a Single Whole-Disease Model. (2020)
Attributed to:
MICA: STRATA - Schizophrenia: Treatment Resistance And Therapeutic Advances
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1001/jamanetworkopen.2020.5888
PubMed Identifier: 32459356
Publication URI: http://europepmc.org/abstract/MED/32459356
Type: Journal Article/Review
Volume: 3
Parent Publication: JAMA network open
Issue: 5
ISSN: 2574-3805